Bank Julius Baer & Co. Ltd Zurich Makes New $77,000 Investment in Cigna Co. (NYSE:CI)


Share on StockTwits

Bank Julius Baer & Co. Ltd Zurich bought a new stake in Cigna Co. (NYSE:CI) during the 4th quarter, Holdings Channel reports. The firm bought 370 shares of the health services provider’s stock, valued at approximately $77,000.

Other institutional investors have also recently bought and sold shares of the company. Iron Horse Wealth Management LLC acquired a new position in shares of Cigna in the fourth quarter valued at approximately $25,000. Front Row Advisors LLC grew its position in shares of Cigna by 76.3% in the third quarter. Front Row Advisors LLC now owns 134 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 58 shares during the last quarter. Addison Advisors LLC acquired a new position in shares of Cigna in the fourth quarter valued at approximately $28,000. Chiron Capital Management LLC acquired a new position in shares of Cigna in the third quarter valued at approximately $29,000. Finally, Jeppson Wealth Management LLC acquired a new position in shares of Cigna in the third quarter valued at approximately $30,000. 87.05% of the stock is currently owned by institutional investors.

Several equities research analysts recently issued reports on the company. Zacks Investment Research cut Cigna from a “hold” rating to a “sell” rating and set a $242.00 price target for the company. in a research note on Monday, March 8th. SVB Leerink boosted their price target on Cigna from $230.00 to $240.00 and gave the company a “market perform” rating in a research note on Monday, December 14th. Deutsche Bank Aktiengesellschaft cut their price target on Cigna from $280.00 to $270.00 and set a “buy” rating for the company in a research note on Friday, February 5th. Truist boosted their price target on Cigna from $260.00 to $280.00 in a research note on Tuesday, March 9th. Finally, Citigroup reiterated a “buy” rating and issued a $273.00 price target on shares of Cigna in a research note on Friday, February 5th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $254.44.

NYSE CI opened at $240.22 on Thursday. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.61. Cigna Co. has a twelve month low of $158.84 and a twelve month high of $248.84. The company has a market cap of $83.45 billion, a price-to-earnings ratio of 16.85, a price-to-earnings-growth ratio of 0.95 and a beta of 0.88. The business’s fifty day moving average is $230.78 and its 200 day moving average is $207.38.

Cigna (NYSE:CI) last released its quarterly earnings data on Wednesday, February 3rd. The health services provider reported $3.51 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $3.68 by ($0.17). Cigna had a net margin of 3.38% and a return on equity of 15.39%. The firm had revenue of $41.71 billion for the quarter, compared to analyst estimates of $40.05 billion. During the same period last year, the business earned $4.31 EPS. The company’s revenue was up 9.1% compared to the same quarter last year. On average, research analysts anticipate that Cigna Co. will post 18.55 earnings per share for the current fiscal year.

In related news, EVP Nicole S. Jones sold 2,527 shares of the firm’s stock in a transaction on Monday, March 1st. The stock was sold at an average price of $212.37, for a total transaction of $536,658.99. Following the completion of the transaction, the executive vice president now directly owns 42,065 shares of the company’s stock, valued at approximately $8,933,344.05. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO David Cordani sold 55,280 shares of the firm’s stock in a transaction on Tuesday, January 12th. The stock was sold at an average price of $225.00, for a total value of $12,438,000.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 152,399 shares of company stock worth $34,096,430. 0.90% of the stock is currently owned by company insiders.

Cigna Profile

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Read More: What is the Dow Jones Industrial Average (DJIA)?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Co. (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.